SEC Company Response from Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Sep 28, 2018
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: Sept. 28, 2018 · CIK: 0001585608 · Accession: 0001104659-18-059410
AI Filing Summary & Sentiment
File numbers found in text: 333-227292
Show Raw Text
CORRESP 1 filename1.htm September 28, 2018 VIA FACSIMILE AND EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Washington, D.C. 20549 Re: JAGUAR HEALTH, INC. Registration Statement on Form S-1 (Registration No. 333-227292) Concurrence in Acceleration Request Ladies and Gentlemen: H.C. Wainwright & Co., LLC (“Wainwright”), as underwriter for the above-referenced offering, hereby concurs in the request by Jaguar Health, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:00 P.M. Eastern Time on Monday, October 1, 2018, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering. Very truly yours, H.C. WAINWRIGHT & CO., LLC By: /s/ Mark Viklund Name: Mark Viklund Title: Chief Executive Officer 430 Park Avenue | New York, New York 10022 | 212.356.0500 Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC